| Entry |
|
|---|
| Name |
Izokibep (USAN/INN) |
|---|
| Formula |
C824H1292N216O276
|
|---|
| Exact mass |
18629.3704
|
|---|
| Mol weight |
18640.35
|
|---|
| Sequence |
AEAKYAKEAD DAAVEIASLP NLTWDQWYAF IQKLRDDPSQ SSELLSEAKK LNDSQAPKAS
GSLAEAKEAA NAELDSYGVS DFYKRLIDKA KTVEGVEALK DAILAALPGT GGGGSAEAKY
AKEADDAAVE IASLPNLTWD QWYAFIQKLR DDPSQSSELL SEAKKLNDSQ APK |
|---|
| Type |
Peptide |
|---|
| Class |
Immunological agent
DG02019 Interleukin inhibitor
|
|---|
| Efficacy |
Anti-inflammatory |
|---|
| Comment |
Affibody molecule
Treatment of non-infectious, non-anterior uveitis
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Immunological agent
DG02019 Interleukin inhibitor
D12278 Izokibep
Target-based classification of drugs [BR:br08310]
Signaling molecules and receptors
Cytokines
Interleukins
IL17A
D12278 Izokibep (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
